Side-by-side comparison of AI visibility scores, market position, and capabilities
Bangalore India credit card sharing platform for family credit line access; $157K 100X.VC seed Jul 2022 acquired by WLDD Feb 2024 after ₹15K annual revenue with IIT alumni team targeting Indian credit access gap.
Credwise Solutions was a Bangalore, India-based fintech startup — backed with $157,000 in seed funding from 100X.VC in July 2022 — that developed a credit card sharing platform enabling credit card holders to share credit lines with family members through prepaid sub-cards, allowing households to consolidate expenses under a single credit line while the primary cardholder maintained monitoring and control. Founded in 2022 by IIT alumni targeting the Indian credit access gap where millions of individuals lack independent credit history but have family members with established credit. Acquired by WLDD on February 5, 2024 after reporting ₹15,000 (approximately $180 USD) in annual revenue as of March 2024, representing an early exit before commercial scale was achieved.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.